07 Apr LSU grad files for patent, working with FDA on drug to stop COVID-19
ATLANTA – A Baton Rouge native and LSU grad said scientists working for her company have found a drug that is showing promise in laboratories at blocking the continued spread of COVID-19.
Darnisha Harrison went to Baton Rouge High and LSU before moving to Georgia. She is the CEO and founder of Ennaid Therapeutics, a pharmaceutical company that develops antiviral drugs. Two weeks ago, she said a patent was filed after scientists discovered a drug showed strong scientific evidence of blocking two proteins that cause COVID-19 from invading healthy host cells and replicating.
The drug is called ENU200 and was previously approved by the FDA for other conditions. The drug is now a repurposed drug and is no longer prescribed.
Read the rest of the story on abc’s WBRZ2 website HERE